Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
15.48
-0.89 (-5.44%)
At close: Jun 3, 2026, 4:00 PM EDT
15.48
0.00 (0.00%)
After-hours: Jun 3, 2026, 4:04 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.6 billion as of June 3, 2026. Its market cap has increased by 119.63% in one year.
Market Cap
1.60B
Enterprise Value
1.15B
1-Year Change
119.63%
Ranking
Category
Stock Price
$15.48
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.60B, an increase of 127.35%. That is a compound annual growth rate of 15.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 1.69B | -11.97% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.77B |
| ADMA Biologics | 1.76B |
| Sarepta Therapeutics | 1.76B |
| Tyra Biosciences | 1.72B |
| Ascentage Pharma Group International | 1.71B |
| uniQure | 1.71B |
| Rapport Therapeutics | 1.71B |
| Nuvation Bio | 1.68B |